Searching map area
Patient-reported outcomes in KEYNOTE-006, a randomised study of pembrolizumab versus ipilimumab in patients with advanced melanoma
? TBD
scientific article published on 3 October 2017
Nobody has rated this yet. Be the first!
Lists 0